SEC Form 4 · accession 0001534424-17-000241
ClearPoint Neuro, Inc. · CLPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kimble L. Jenkins
Director
Period of report
May 26, 2017
Accepted (ET)
May 30, 2017 · 4:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001285550
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 26, 2017 | P$0 | 7,500 | — | A | 34,638 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrants (right to buy)F1,F2 | $2.20 | May 26, 2017 | P | 7,500 | A | May 26, 2017 | May 26, 2022 | Common Stock | 7,500 | 7,500 | D |
Explanation of responses
- F1The reported securities are included within 7,500 units purchased by the Reporting Person for $2.00 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock.
- F2The shares subject to this warrant are immediately exercisable.